Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C66H120N12O13S |
| Molecular Weight | 1321.797 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 13 / 13 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]1([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)(C)O)N(C)C(=O)[C@@H](SCCN(C)C)N(C)C(=O)[C@H](CC)NC1=O)C(C)C
InChI
InChIKey=AQHMBDAHQGYLIU-XNFHFXFQSA-N
InChI=1S/C66H120N12O13S/c1-27-29-30-42(13)53(79)52-57(83)69-45(28-2)59(85)78(26)65(92-32-31-71(18)19)64(90)75(23)49(36-66(16,17)91)56(82)70-50(40(9)10)62(88)72(20)46(33-37(3)4)55(81)67-43(14)54(80)68-44(15)58(84)73(21)47(34-38(5)6)60(86)74(22)48(35-39(7)8)61(87)76(24)51(41(11)12)63(89)77(52)25/h27,29,37-53,65,79,91H,28,30-36H2,1-26H3,(H,67,81)(H,68,80)(H,69,83)(H,70,82)/b29-27+/t42-,43+,44-,45+,46+,47+,48+,49+,50+,51+,52+,53-,65-/m1/s1
| Molecular Formula | C66H120N12O13S |
| Molecular Weight | 1321.797 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 13 / 13 |
| E/Z Centers | 1 |
| Optical Activity | UNSPECIFIED |
SCY-635 is a nonimmunosuppressive cyclosporine-based analog that exhibits potent suppression of hepatitis C virus (HCV) replication. SCY-635 has reached the phase II clinical trial for the treatment of patients with hepatitis C Infection. In addition, in the preclinical model, the SCY-635 was studied for the treatment of hepatitis-B in USA.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| SCY-635, a novel nonimmunosuppressive analog of cyclosporine that exhibits potent inhibition of hepatitis C virus RNA replication in vitro. | 2010 Feb |
|
| The cyclophilin inhibitor SCY-635 disrupts hepatitis C virus NS5A-cyclophilin A complexes. | 2012 Jul |
|
| The cyclophilin inhibitor SCY-635 suppresses viral replication and induces endogenous interferons in patients with chronic HCV genotype 1 infection. | 2012 Jul |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:05:18 GMT 2023
by
admin
on
Sat Dec 16 10:05:18 GMT 2023
|
| Record UNII |
WSU5343074
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
210759-10-7
Created by
admin on Sat Dec 16 10:05:18 GMT 2023 , Edited by admin on Sat Dec 16 10:05:18 GMT 2023
|
PRIMARY | |||
|
6479267
Created by
admin on Sat Dec 16 10:05:18 GMT 2023 , Edited by admin on Sat Dec 16 10:05:18 GMT 2023
|
PRIMARY | |||
|
DB12451
Created by
admin on Sat Dec 16 10:05:18 GMT 2023 , Edited by admin on Sat Dec 16 10:05:18 GMT 2023
|
PRIMARY | |||
|
WSU5343074
Created by
admin on Sat Dec 16 10:05:18 GMT 2023 , Edited by admin on Sat Dec 16 10:05:18 GMT 2023
|
PRIMARY | |||
|
DTXSID00175303
Created by
admin on Sat Dec 16 10:05:18 GMT 2023 , Edited by admin on Sat Dec 16 10:05:18 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
